Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis.
acquired factor V inhibitor
biological tests
haemodialysis
thrombosis
Journal
Annales de biologie clinique
ISSN: 1950-6112
Titre abrégé: Ann Biol Clin (Paris)
Pays: France
ID NLM: 2984690R
Informations de publication
Date de publication:
01 Apr 2020
01 Apr 2020
Historique:
entrez:
23
4
2020
pubmed:
23
4
2020
medline:
24
9
2020
Statut:
ppublish
Résumé
Factor V deficiency is a rare hemostatic disorder. It may present with a diverse spectrum of symptoms due to a variety of mechanisms including development of autoantibodies associated with a number of conditions. We report a first case of factor V deficiency in Tunisian hemodialysis patient due to an autoantibody most likely secondary to antibiotic exposure responsible for an arteriovenous shunt thrombosis rather than bleeding. We discuss here the clinical and biological features of acquired factor V inhibitor and provide a short review of the current literature.
Identifiants
pubmed: 32319951
pii: abc.2020.1540
doi: 10.1684/abc.2020.1540
doi:
Substances chimiques
Autoantibodies
0
Factor V
9001-24-5
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM